Skip to main content
Exclusive Savings: Take 10% OFF All Cenmed Products | Upgrade Your Lab For Less Shop Now
US English

ALADDIN SCIENTIFIC

BAY-1816032

BAY-1816032 BAY-1816032 is a potent and oral available inhibitor of budding uninhibited by benzimidazoles 1 (BUB1) kinase with IC50 of 6.1 nM for recombinant catalytic domain of human BUB1.

Description

BAY-1816032 BAY-1816032 is a potent and oral available inhibitor of budding uninhibited by benzimidazoles 1 (BUB1) kinase with IC50 of 6.1 nM for recombinant catalytic domain of human BUB1. BAY-1816032 has antitumor activity.TargetsBUB1 (Cell-free assay) 6.1 nMIn vitroBAY 1816032 is a novel, bioavailable inhibitor of the catalytical activity of the mitotic checkpoint protein BUB1, which is involved in centromere cohesion and attachment error correction. Inhibition of BUB1 sensitizes tumor cells towards paclitaxel and docetaxel, and towards ATR inhibitors and PARP inhibitiors.In vivoIn xenograft models of triple-negative breast cancer BAY 1816032 in combination with paclitaxel or olaparib strongly delays outgrowth of tumors under treatment as compared to paclitaxel or olaparib single agents.Cell Research(from reference)Cell lines:HeLa, SUM-149, MDA-MB-436, NCI-H1299, 22RV1, H4 cells. Concentrations:0.1 μM to 10 μM Incubation Time:4 h, 24 h, 48 h, 72 h, 96 h


Serine/threonin kinase Inhibitors


Specifications & Purity: BAY-1816032 BAY-1816032 is a potent and oral available inhibitor of budding uninhibited by benzimidazoles 1 (BUB1) kinase with IC50 of 6.1 nM for recombinant catalytic domain of human BUB1. BAY-1816032 has antitumor activity.TargetsBUB1 (Cell-free assay) 6.1 nMIn vitroBAY 1816032 is a novel, bioavailable inhibitor of the catalytical activity of the mitotic checkpoint protein BUB1, which is involved in centromere cohesion and attachment error correction. Inhibition of BUB1 sensitizes tumor cells towards paclitaxel and docetaxel, and towards ATR inhibitors and PARP inhibitiors.In vivoIn xenograft models of triple-negative breast cancer BAY 1816032 in combination with paclitaxel or olaparib strongly delays outgrowth of tumors under treatment as compared to paclitaxel or olaparib single agents.Cell Research(from reference)Cell lines:HeLa, SUM-149, MDA-MB-436, NCI-H1299, 22RV1, H4 cells. Concentrations:0.1 μM to 10 μM Incubation Time:4 h, 24 h, 48 h, 72 h, 96 h


Molecular Formula: C27H24F2N6O4


Molecular Weight: 534.51


PubChem CID: 118958833


Isomeric SMILES: COC1=CN=C(N=C1NC2=C(C=NC=C2)OC)C3=NN(C4=CC=CC=C43)CC5=C(C=C(C=C5F)OCCO)F


Storage Temperature: Store at -20°C


Shipped in: Ice chest + Ice pads


Specifications
UPC:
51442306
Weight:
1.06 Ounces
HazmatClass:
Yes
Quantity:
1
Unit of Measurement:
EA
WeightUOM:
LB
MPN:
B414286-1mg
Country of Origin:
China
CAS:
1891087-61-8
Product Size:
1mg
Harmonized Tariff Code:
2931.90.90
Catalog No. C008B-272886
Price: $136.56
List Price: $151.73
  • Guaranteed quality & reliable delivery
  • Shipping Lead-Time: 14-21 Days
Adding to cart… The item has been added
Request a Quote

Enjoy exclusive benefits, including discounted pricing on bulk orders, by opening a Cenmed Business Account. Learn More.